Tag: FDA
Browse our exclusive articles!
FDA considers boosters for all adults amid threat of winter surger
When the Supreme Court ended the Biden administration’s eviction moratorium in late August, some advocates expected a flash flood of evictions. Instead, it’s been more like a slow-moving mudslide, reports Sophie Kasakove in The New York Times.
What’s All The Buzz About Quercetin?
Quercetin has been in the news lately, particularly as one of many potential therapeutics that might have some benefit in the prevention or treatment of COVID infection. Is there anything to this?
FDA advisers back Pfizer’s COVID-19 vaccine for young kids
A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.
Why COVID boosters weren’t tweaked to better match variants
More COVID-19 booster shots may be on the way -- but when it’s your turn, you’ll get an extra dose of the original vaccine, not one updated to better match the extra-contagious delta variant.
More questions for J&J vaccine boosters ahead of FDA review
The Food and Drug Administration is wrestling with whether and when to offer another dose of the single-shot Johnson & Johnson COVID-19 vaccine, while a new study out Wednesday raises the prospect that using a different brand as the booster might work better.
